David Mardle

Current View:

This content is provided by David Mardle.

Practice Areas

David Mardle is a partner in Goodwin’s Technology and Life Sciences group with 20 years of experience advising on financings and M&A transactions in the life sciences and technology sectors. Leveraging his significant M&A experience combined with his general corporate and capital markets expertise, Mr. Mardle now concentrates his focus on representing emerging biotech companies providing counsel on corporate and capital markets transactions.


Prior to joining Goodwin in 2019, Mr. Mardle was a partner at Taylor Wessing LLP.